The Aptima SARS-CoV-2/Flu Assay from Hologic is now available for commercial use in North America and Europe. The test can simultaneously identify SARS-CoV-2, influenza A and influenza B. The test runs on the company’s fully automated Panther system, which can conduct over 1,000 tests in 24 hours and delivers preliminary results in nearly three hours. The assay has obtained a CE-mark for diagnostic testing in Europe and is authorised for use in Canada and the US.
